SuperworthCVS Health Corp. CVS
Medical - Healthcare Plans, Healthcare
$87.95
+1.76%
- Market cap
- $112.5B
- PE
- 23.3×
- 10y median 16.2×
- Forward PE
- Price to sales
- 0.3×
- EV/EBIT
- 11.2×
- Revenue, 12 months
- $415.1B
- +7% on a year ago
- Net margin
- 1.2%
- Free cash flow yield
- 10.5%
CVS Health trades at 23.3× trailing earnings, pricier than 78% of the last ten years. Revenue was $415.1B over the last twelve months, up 7% on a year earlier with a 1% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| $93.8B | $88.4B | $91.2B | $95.4B | $97.7B+4% | $94.6B+7% | $98.9B+8% | $102.9B+8% | $105.7B+8% | $100.4B+6% | $106.1B+7% | |
| Cost of revenue | $22.5B | $27.8B | $27.9B | $29.9B | $29.5B+31% | $29.1B+5% | $31.3B+12% | $32B+7% | $33.1B+12% | $29.4B+1% | $31.5B+1% |
| Gross profit | $71.3B | $60.6B | $63.4B | $65.5B | $68.2B−4% | $65.5B+8% | $67.6B+7% | $70.9B+8% | $72.6B+7% | $71.1B+9% | $74.6B+10% |
| $3.4B | $2.3B | $3B | $832M | $2.4B−30% | $3.4B+49% | $2.4B−22% | −$3.2B | $2.1B−11% | $4.7B+39% | $4.7B+98% | |
| Interest expense | $690M | $716M | $732M | $752M | $758M+10% | $785M+10% | $763M+4% | $784M+4% | $787M+4% | $774M−1% | $757M−1% |
| Pre-tax income | $2.7B | $1.6B | $2.3B | $105M | $2.1B−21% | $2.6B+66% | $1.6B−30% | −$3.5B | $1.4B−36% | $3.9B+51% | $4B+142% |
| $658M | $456M | $569M | $34M | $503M−24% | $835M+83% | $634M+11% | $508M+1394% | −$1.6B | $981M+18% | $982M+55% | |
| Net income | $2B | $1.1B | $1.8B | $87M | $1.6B−20% | $1.8B+60% | $1B−42% | −$4B | $2.9B+79% | $2.9B+65% | $3B+192% |
| $1.59 | $0.88 | $1.41 | $0.07 | $1.30−18% | $1.41+60% | $0.80−43% | −$3.13 | $2.30+77% | $2.30+63% | $2.31+189% | |
| 1.3B | 1.3B | 1.3B | 1.3B | 1.3B−3% | 1.3B−0% | 1.3B+1% | 1.3B+1% | 1.3B+1% | 1.3B+1% | 1.3B+1% |
From each company's 10-Q and 10-K filings. Fiscal years are four fiscal quarters added up; balance sheet lines are as of the period's end. Growth is on the same period a year earlier.
Estimates
Next earnings report: .
Analyst consensus for the next eight quarters, with the range from the lowest to the highest estimate, is part of Superworth Pro.
Peers
Companies in Medical - Healthcare Plans within ten times CVS Health's size, closest in size first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| CVSCVS Health Corp. | $112.5B | 23.3× | 16.2× | 0.3× | +7% | 1.2% | |
| ELVElevance Health Inc. | $87.7B | 18.0× | 17.6× | 0.4× | +6% | 2.5% | |
| CICigna Corporation | $73.6B | 11.5× | 16.1× | 0.3× | +8% | 2.3% | |
| HUMHumana Inc. | $47.6B | 37.5× | 20.5× | 0.3× | +18% | 0.9% | |
| UNHUnitedHealth Group Incorporated | $337.5B | 24.2× | 22.4× | 0.7× | +6% | 3.1% | |
| Peer median | $80.6B | 21.1× | 19.1× | 0.4× | +7% | 2.4% |
About
- Industry
- Medical - Healthcare Plans
- Sector
- Healthcare
Valuation data, not investment advice. Prices as of .